title: Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
abstract: Human botulism is commonly associated with botulinum neurotoxin (BoNT) serotypes A, B, E and F. This suggests that the greatest need is for a tetravalent vaccine that provides protection against all four of these serotypes. In current study, we investigated the feasibility of generating several tetravalent vaccines that protected mice against the four serotypes. Firstly, monovalent replicon vaccine against BoNT induced better antibody response and protection than that of corresponding conventional DNA vaccine. Secondly, dual-expression DNA replicon pSCARSE/FHc or replicon particle VRP-E/FHc vaccine was well resistant to the challenge of BoNT/E and BoNT/F mixture as a combination vaccine composed of two monovalent replicon vaccines. Finally, the dual-expression DNA replicon or replicon particle tetravalent vaccine could simultaneously and effectively neutralize and protect the four BoNT serotypes. Protection correlated directly with serum ELISA titers and neutralization antibody levels to BoNTs. Therefore, replicon-based DNA or particle might be effective vector to develop BoNT vaccines, which might be more desirable for use in clinical application than the conventional DNA vaccines. Our studies demonstrate the utility of combining dual-expression DNA replicon or replicon particle vaccines into multi-agent formulations as potent tetravalent vaccines for eliciting protective responses to four serotypes of BoNTs.
authors.affiliation: Beijing Institute of Biotechnology, Beijing, China. yunzhouyu@163.com
authors.forename: Yun-Zhou
authors.initials: YZ
authors.lastname: Yu
authors.forename: Jin-Peng
authors.initials: JP
authors.lastname: Guo
authors.forename: Huai-Jie
authors.initials: HJ
authors.lastname: An
authors.forename: Shu-Ming
authors.initials: SM
authors.lastname: Zhang
authors.forename: Shuang
authors.initials: S
authors.lastname: Wang
authors.forename: Wei-Yuan
authors.initials: WY
authors.lastname: Yu
authors.forename: Zhi-Wei
authors.initials: ZW
authors.lastname: Sun
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D001905:Botulinum Toxins / Q000145:classification* / Q000235:genetics / Q000276:immunology*; D001906:Botulism / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D003014:Clostridium botulinum / Q000737:chemistry / Q000472:pathogenicity; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005822:Genetic Vectors / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D009498:Neurotoxins / Q000145:classification / Q000235:genetics / Q000276:immunology*; D012093:Replicon / Q000235:genetics*; D012672:Semliki forest virus / Q000235:genetics*; D019444:Vaccines, DNA / Q000235:genetics* / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D009498:Neurotoxins; D019444:Vaccines, DNA; D001905:Botulinum Toxins